The Footnote

Serve Truth. Confront power.

Author attribution not recorded

A single bright light illuminating a path through a dark, shadow-filled bureaucracy.

The intellectual’s duty is to serve truth, which—sooner or later—means confronting power.

There it is—the line most of us nod at in public and avoid in private. It sounds noble on a poster and inconvenient in a clinic. Because “truth” is not just an abstract good; it’s a lever. And levers move things—budgets, egos, markets, careers. That means they meet resistance.

I’m writing this for clinicians, policy-wonks, researchers, and the unglamorous army of allied health professionals who notice the uncomfortable pattern beneath the press release. The pattern is simple: if you follow outcomes honestly, you end up bumping into power. Not villainous, cape-swishing power—more the slow-moving, self-confident kind that assumes it is neutral, inevitable, and therefore beyond audit.

What truth actually demands in healthcare

Let’s get concrete. Truth in healthcare is not a philosophical vibe; it’s measurable reality landing on human bodies. It shows up as:

Reduction in pain and disability that patients can feel and describe.

Function regained—walking further, sleeping through pain, playing with kids, returning to work.

Avoided harm—fewer adverse events, fewer amputations, less polypharmacy for symptoms we could treat mechanically or behaviourally.

Value—not “cheapness,” but benefit per dollar per person, measured across time, not just a quarter.

Follow those threads long enough and three myths begin to wobble.

Myth 1: Neutrality

We love to act as if guidelines and funding instruments float above politics. They don’t. Benefit schedules, credentialing rules, referral pathways, the shape of multidisciplinary teams—these are power-laden decisions. When podiatry (or physio, or dietetics) sits outside direct funding streams, that isn’t a clinical choice; it’s a historical and political one. If your service is framed as optional “extras,” the data can be flawless and still lose to a louder lobby.

The neutral pose is tempting because it keeps rooms calm. But neutrality is a decision in favour of the current winners. Serving truth means being explicit about where neutrality hides a preference—who gets funded to do what, who is permitted to prescribe, who is allowed to lead, who may bill directly, whose outcomes “count.”

Myth 2: Data will save us (all by itself)

I love data. I also know how easily it is gamed. We measure what we can invoice for. We optimise what we measure. Soon enough, the metric replaces the mission. The spreadsheet looks improved while the patient is still limping.

Serving truth means insisting that measurement traces the arc of a person’s life, not the contours of a funding form. If we want fewer ulcers, fewer amputations, fewer opioid scripts, fewer days lost to avoidable pain, then we must measure those things longitudinally—across providers and payers—and tie funding to them. Not once. Not as a pilot. As routine.

Myth 3: The market will sort it out

Markets are good at some problems. They are spectacular at creating convenience and spectacle. They are less gifted at producing quiet, compounding, long-horizon public goods like community mobility, prevention, and multidisciplinary care for complex, chronic conditions.

Serving truth means naming where market logics—debt-fuelled rollups of clinics, incentive schemes that treat clinicians like sales reps, brand-led footwear that undermines biomechanics while selling “comfort”—collide with patient outcomes. We can love enterprise and still draw a bright line around public money and essential services. That tension isn’t anti-business; it’s pro-health.

Where this gets personal

I’ve worked in systems that worship brilliance and systems that reward reliability. I’ve seen the radiotherapy machine hum at perfect isocentre, and I’ve watched a patient’s gait tell the story a scan could not. Across settings, one law holds: when you centre outcomes, hierarchies get itchy.

  • Say out loud that allied health should bill directly for the things it does best, and you confront a hierarchy.

  • Show that simple mechanical interventions reduce scripts and surgical lists, and you confront a business model.

  • Publish a series that links private equity rollups to care fragmentation, and you confront the comfort of “it’s just capital.”

  • Ask why adverse events are under-reported, and you confront colleagues who prefer reputational quiet to clinical learning.

None of that is a crusade. It’s adult supervision.

The cost of deference

Deference looks harmless. It sounds collegial. It keeps meetings short. But it’s expensive.

For patients: Deference delays the better idea. It extends pain. It normalises disability that could have been avoided with earlier, more appropriate care.

For clinicians: Deference breeds moral injury—when you know the right care, but the system won’t let you deliver it.

For the system: Deference calcifies legacy pathways, creating bottlenecks that cost multiples downstream (ulcers that become amputations, tendinopathies that become ruptures, heel pain that becomes inactivity that becomes cardiometabolic disease).

If we priced the compound interest of deference, we’d treat confronting power as a duty of care, not a personality quirk.

What confronting power looks like on Tuesdays

Grand manifestos are useless if they don’t survive Tuesday afternoon. Here’s the mundane shape of courage:

1) Write outcomes into your routine, not your resume. Ask every patient: What matters most to you in six weeks? Twelve? Record it. Re-ask it. Plot it. If your clinic software can’t display that trajectory, build a simple spreadsheet and make it communal. When outcomes become a shared wall chart, the room changes. The conversation moves from “what did I do?” to “what is working?”

2) Publish your lower legs, not your LinkedIn. Share anonymised, longitudinal outcome snapshots—pain scores with functional anchors, walking distance, return-to-work days, re-ulceration rates—aggregated by diagnosis and intervention. Keep the measures humble and the time horizon real (3, 6, 12 months). This isn’t to flex; it’s to invite comparison. Competition is healthy when the scoreboard is patient-centred.

3) Treat funding rules as drafts, not commandments. Work within them; argue beyond them. When a rule irrationally blocks a patient from the right care at the right time, document the harm and escalate. Use case series, not vibes. Policymakers don’t wake up plotting to misallocate resources; they respond to well-framed, repeated evidence that their current settings are under-delivering.

4) Build coalitions that ignore job titles. Outcomes improve when the best-placed clinician leads the slice of care where they have comparative advantage. Sometimes that’s a surgeon. Often it’s not. Make meetings where podiatrists, physios, nurses, pharmacists, and GPs decide together what pathway beats pain, prevents recurrence, and reduces collateral prescribing. Put the patient in the room and the incentives on the table.

5) Refuse theatre, demand transparency. If your service trumpets innovation but won’t publish its re-attendance, escalation, and complication rates, that’s theatre. If your vendor sells “support” that collapses by month three, that’s theatre. If your professional body treats workforce burnout as a branding risk rather than a practice risk, that’s theatre. Ask for the numbers kindly and publicly. Silence is an answer.

6) Care for the whistle you might have to blow. Not every problem is a scandal. But some are. Document contemporaneously. Seek advice early. Protect the patient first, yourself second, the institution third. If you think that order is naive, ask a patient which order they assumed you lived by.

The Footnote: a home for honest friction

The Footnote exists because the “main text” of health policy is too tidy. The footnotes are where the messy truth lives: the caveats, the conflicts, the uncomfortable graphs, the fixation on shiny tech while a $40 intervention saves a limb, the polite myths about “scope” that quietly ration care.

Our mission is not to antagonise for sport. It’s to create a space where practitioners can say, “Here is what’s actually happening; here is what worked; here is what failed; here is the rule that got in the way; here is the rule that helped; here is the number that convinced the policymaker; here is the chart that changed the meeting.” That is confronting power by boring it into agreement.

On outcomes (and shoes, and surgery, and sales)

If you want to see power in miniature, walk through a footwear store with a clinician’s eye. The marketing is loud. The biomechanics are quiet. Patients buy narratives. Many clinicians do too. We can laugh at cushioning fads, but the pattern scales: health systems buy narratives about “integration,” “innovation,” and “efficiency” while the basics of access, continuity, and professional autonomy go underfunded.

Confronting power means naming the mismatch between what glitters and what works, from orthoses that stabilise a collapsing chain to simple load-management that rescues a tendon without an injection. There is nothing anti-science about simplicity. There is nothing anti-surgery about prevention. There is nothing anti-business about insisting that public money purchases public value.

Courage without swagger

This part matters. Confrontation is a stance toward reality, not a performance. Humility is the foundation:

Be falsifiable. Publish predictions. If you say a pathway reduces re-ulceration by 30% at 12 months, show your working. If you’re wrong, you learned; if you’re right, you persuaded.

Be local before you’re loud. Fix the process in front of you. Then tell others how. The power you confront should be the power you’ve already outperformed.

Be kind. Most of the “power” you will meet is not a moustache-twirling villain. It’s a harried committee, a legacy billing code, a bad incentive. Aim at systems, not scapegoats.

Risk, and why it’s still worth it

Speaking up could cost you reputation, contracts, committee seats, sponsorships. That’s real. But silence costs your patients more. And it costs you something you can’t invoice for: the sense that your professional life matches your professional ethics.

There’s also this: truth compounds. Publish one honest series of outcomes, and a colleague in another clinic does the same. Challenge one perverse rule with a clean, repeated dataset, and a policymaker quietly fixes it. Refuse one piece of theatre, and an entire department saves its time for patients. Courage scales when it is mundane, methodical, and measurable.

A short playbook for the next 90 days

Not a manifesto—just a workable start.

Week 1–2: Define the patient-centred outcomes you’ll track. Pick 3–5 per condition: pain with functional anchors, walking distance, return-to-work days, re-ulceration, re-attendance. Keep the questions short, consistent, and recorded at baseline, 6 weeks, 12 weeks.

Week 3–4: Build the collection habit. Add prompts to your intake and discharge. Train the team to ask and record the same way, every time. If the software fights you, create a shared sheet everyone can see.

Week 5–6: Visualise and share internally. Turn rows into simple graphs on a shared screen. Discuss what’s working in weekly huddles. Adjust care pathways based on what the data (and patients) say, not what the strongest personality prefers.

Week 7–8: Publish a de-identified snapshot. Write a 500-word summary of one condition: baseline vs 12-week outcomes, what changed, what didn’t, what you’ll try next. No grand claims. Just candour.

Week 9–12: Escalate one systemic barrier. Pick a rule, contract term, or referral habit that clearly gets in the way. Draft a one-page brief: the problem, the data, the patient impact, the low-risk fix. Send it up with an invitation to visit your clinic and see the pathway working.

That’s it. That is confronting power without theatrics: measure, share, improve, repeat, escalate.

Final word (and a promise)

Serving truth is the job description we didn’t get printed on our lanyards. It is less romantic than the quote suggests and far more satisfying. The point is not to win a fight; it’s to win a future in which ordinary clinical days produce extraordinary public value—because the system finally points in the same direction as the evidence, the ethics, and the patient.

The Footnote will keep publishing the awkward graphs, the simple fixes, the questions that make comfortable rooms a little less comfortable. We’ll be wrong sometimes. We’ll correct it. We’ll keep the receipts. And we’ll keep returning to that duty line—not as a slogan, but as a habit:

Serve truth. Confront power. Then get back to clinic.